View Author

Oomen, M.H.

( M.H. Oomen)


expression tumor cancer androgen prostate model androgen withdrawal differentiation tissue protein castration level -295 xenograft -310 prostate cancer prostatic withdrawal antibody marker neuroendocrine differentiation growth neuroendocrine pc -295 model analysis staining receptor sgiii postcastration study control number culture 21 days pc -310 model androgen receptor slide progression androgen deprivation patient volume minute -310c pc -295 pc -310 xenograft van der kwast factor blastemal androgen-dependent neuropeptide 10 min result immunohistochemical 21 days postcastration androgen receptor expression pc -310c cultures 7 b 2 steenbrugge phenotype pathol secretory pathway point induction kwast secretory 5- ht epithelial rt-pcr prognostic value ar expression secretogranin schroder pc -310c time point 4 days blastemal wt proliferation non-ne cells pc -310 pc -310 tumors




3 Most Recent Publications

Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation (Article)
Jongsma, J. Oomen, M.H. Noordzij, M.A. Weerden, W.M. van Martens, G.J. Kwast, Th.H. van der Schröder, F.H. Steenbrugge, G.J. van
2000-01-01
Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma (Article)
Ghanem, M.A. Kwast, Th.H. van der Hollander, J.C. den Sudaryo, M.K. Oomen, M.H. Noordzij, M.A. Heuvel, M.M. van den Nassef, S.M. Nijman, J.M. Steenbrugge, G.J. van
2000-01-01
Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model (Article)
Jongsma, J. Oomen, M.H. Noordzij, M.A. Weerden, W.M. van Martens, G.J. Kwast, Th.H. van der Schröder, F.H. Steenbrugge, G.J. van
1999-01-01